FindTrial
Sign In

An observational study on the safety and efficacy of Novel Coronavirus (COVID-19) vaccine in population with different characteristics

An observational study on the safety and efficacy of Novel Coronavirus (COVID-19) vaccine in population with different characteristics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048549
Enrollment
Unknown
Registered
2021-07-10
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Population:Novel Coronavirus vaccine

Sponsors

Ningbo First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. All recipients of the COVID-19 vaccine; 3. Willing to participant in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
pain;flush;swelling;Nausea and vomiting;diarrhea;rash;headache;dizzy;fatigue;chill;Sore throat;cough;chest distress;heart palpitation;Muscle pain;Joint pain;fever;new coronavirus antibodies;—

Countries

China

Contacts

Public ContactChao Cao

Ningbo First Hospital

caocdoctor@163.com+86 18258796161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026